Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease.
Neurosci Lett
; 379(3): 195-8, 2005 May 13.
Article
em En
| MEDLINE
| ID: mdl-15843062
ABSTRACT
Pantothenate kinase-associated neurodegeneration (PKAN) may serve as a model for Parkinson disease (PD) since many PKAN patients suffer from parkinsonism and both conditions lead to iron accumulation in the basal ganglia. We screened the gene coding for pantothenate kinase 2 (PANK2) for sequence variants in PD. We found no mutations in 67 PD patients with affected sibs or early-onset disease. Moreover, PANK2 polymorphisms were not associated with late-onset idiopathic PD in 339 patients. We conclude that PANK2 variants exert, if any, only a very small effect in the genetic risk of PD.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Doença de Parkinson
/
Fosfotransferases (Aceptor do Grupo Álcool)
/
Mutação
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2005
Tipo de documento:
Article